Scope 3 Emissions Estimator
for Healthcare

Scope 3 emissions estimation for Healthcare

Healthcare entities generate Scope 3 emissions through a supply chain that includes pharmaceuticals, medical devices, clinical consumables, food services, laundry, patient transport, and waste treatment. Research published by Health Care Without Harm estimates that supply chain emissions (predominantly Category 1) account for approximately 71% of a healthcare system's total carbon footprint. The NHS England Greener NHS programme published data showing that the NHS's Scope 3 emissions were 16.3 million tonnes CO2e in 2019, compared to combined Scope 1 and Scope 2 of approximately 7.2 million tonnes. For healthcare entities subject to CSRD, ESRS E1-6 requires disclosure of these upstream emissions, and the sector's reliance on single-use products, energy-intensive pharmaceutical manufacturing, and cold-chain logistics makes the Scope 3 calculation both large and methodologically demanding.

The dominant categories for healthcare are Category 1 (pharmaceuticals, medical devices, consumables, food, laundry services, IT), Category 5 (waste generated in operations, including clinical waste requiring incineration or high-temperature treatment), and Category 4 (upstream transport of medical supplies, often with cold-chain requirements that increase energy intensity). Category 7 (employee commuting) is significant for hospitals with thousands of staff operating shift patterns that do not align with public transport schedules. Category 2 (capital goods) covers medical imaging equipment, surgical robots, and building fit-outs that carry substantial embodied carbon. The pharmaceutical supply chain presents particular data challenges. Active pharmaceutical ingredients are manufactured through multi-step chemical synthesis with emission profiles that vary by process, scale, and geography. Generic factors published by DEFRA or ecoinvent for pharmaceutical products carry uncertainty ranges exceeding 50%. The NHS has developed the Evergreen Sustainable Supplier Assessment to collect supplier-specific emission data, but coverage remains patchy outside the UK public health system.

Assurance findings in healthcare Scope 3 reporting centre on four issues. Waste classification drives Category 5 calculations, and hospitals that misclassify general waste as clinical waste (or vice versa) distort their emission estimates because incineration emission factors are substantially higher than landfill or recycling factors. Pharmaceutical procurement data is often recorded by cost rather than by physical quantity, forcing reliance on spend-based factors that cannot distinguish between a high-cost, low-carbon biologic and a low-cost, high-carbon bulk chemical. Staff travel surveys used for Category 7 often achieve response rates below 30%, which introduces sampling bias. Medical device manufacturers rarely provide product carbon footprint data, leaving hospitals to estimate embodied emissions from device weight and material composition using proxy factors.

For healthcare entities using this estimator, segment your procurement into pharmaceuticals, medical devices, consumables, food services, facilities management, IT, and professional services. Apply DEFRA emission factors by spend category as a baseline, then upgrade to supplier-specific data for your top 10 suppliers by spend (which typically cover 40% to 50% of total procurement value). For waste, obtain tonnage data by waste stream (clinical infectious, clinical non-infectious, pharmaceutical, general, recyclable) and apply the appropriate treatment-method emission factors from DEFRA or the relevant national waste agency. For employee commuting, use HR data on staff headcount by site, combined with national transport statistics for average commuting distance and mode split, adjusted for your site locations.